Heparanase-induced shedding of syndecan-1/CD138 in myeloma and endothelial cells activates VEGFR2 and an invasive phenotype: prevention by novel synstatins

Multiple myeloma arises when malignant plasma cells invade and form multiple tumors in the bone marrow. High levels of heparanase (HPSE) correlate with poor prognosis in myeloma patients. A likely target of the enzyme is the heparan sulfate (HS) proteoglycan syndecan-1 (Sdc1, CD138), which is highly...

全面介紹

Na minha lista:
書目詳細資料
發表在:Oncogenesis
Main Authors: Jung, O, Trapp-Stamborski, V, Purushothaman, A, Jin, H, Wang, H, Sanderson, R D, Rapraeger, A C
格式: Artigo
語言:Inglês
出版: Nature Publishing Group 2016
主題:
Original Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5154350/
https://ncbi.nlm.nih.gov/pubmed/26926788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/oncsis.2016.5
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍